Ramtin Agah - 11 Apr 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Issuer symbol
RNXT
Transactions as of
11 Apr 2025
Net transactions value
+$16,000
Form type
4
Filing time
14 Apr 2025, 06:30:30 UTC
Previous filing
10 Apr 2025
Next filing
16 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase $16,000 +20,000 +1.9% $0.8000 1,098,460 11 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases of the Issuer's securities.